Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Loice Achieng Ombajo

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Plos One|June 23, 2023
High rates of kidney impairment among older people (≥ 60 years) living with HIV on first-line antiretroviral therapy at screening for a clinical trial in KenyaJeremy Penner, Loice Achieng Ombajo, Davies Otieno, et al.
Globalization and Health|April 4, 2025
Reserve antibiotics: overcoming limitations of evidence generated from regulatory approval trialsLorenzo Moja, Mohamed Abbas, Marlieke Ea de Kraker, et al.
The Pan African Medical Journal|January 15, 2020
Empyema necessitans due to aspergillus in a 3-year-old paediatric patient at a referral hospital in Nairobi, KenyaAnne-Marie Macharia, Loice Achieng Ombajo, Abdirahman Hashi Farah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 26, 2024
Change in Blood Pressure, Weight, and Other Cardiovascular Disease Risk Factors After Switch From Protease Inhibitors to Dolutegravir: Post hoc Analysis of the 48-week Randomised Second-line Switch to Dolutegravir TrialLoice Achieng Ombajo, Jeremy Penner, Joseph Nkuranga, et al.
Epidemics|July 22, 2022
Infectious disease modelling for SARS-CoV-2 in Africa to guide policy: A systematic reviewTeresia Njoki Kimani, Mutono Nyamai, Lillian Owino, et al.
The Lancet. HIV|May 2, 2024
Two-drug regimens for the treatment of HIV in AfricaIvan Mambule, Claire Norcross, Loice Achieng Ombajo, et al.
The Lancet. Global Health|August 12, 2022
The COVID-19 pandemic and disruptions to essential health services in Kenya: a retrospective time-series analysisHelen Kiarie, Marleen Temmerman, Mutono Nyamai, et al.
Open Forum Infectious Diseases|November 24, 2025
First-Line Switch to B/F/TAF for Treatment of HIV in Older Adults ≥60 Years in Kenya (the B/F/TAF-Elderly Study)Loice Achieng Ombajo, Jeremy Penner, Joseph Nkuranga, et al.
IJID Regions|October 21, 2024
Investigation and successful control of a <i>Candida auris</i> outbreak at a tertiary health care facility in KenyaLoice Achieng Ombajo, Alice Kanyua, Rose Ngugi, et al.
BMJ Open|May 19, 2022
Epidemiological and clinical characteristics of patients hospitalised with COVID-19 in Kenya: a multicentre cohort studyLoice Achieng Ombajo, Nyamai Mutono, Paul Sudi, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Plos One|June 23, 2023
High rates of kidney impairment among older people (≥ 60 years) living with HIV on first-line antiretroviral therapy at screening for a clinical trial in KenyaJeremy Penner, Loice Achieng Ombajo, Davies Otieno, et al.
Globalization and Health|April 4, 2025
Reserve antibiotics: overcoming limitations of evidence generated from regulatory approval trialsLorenzo Moja, Mohamed Abbas, Marlieke Ea de Kraker, et al.
The Pan African Medical Journal|January 15, 2020
Empyema necessitans due to aspergillus in a 3-year-old paediatric patient at a referral hospital in Nairobi, KenyaAnne-Marie Macharia, Loice Achieng Ombajo, Abdirahman Hashi Farah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 26, 2024
Change in Blood Pressure, Weight, and Other Cardiovascular Disease Risk Factors After Switch From Protease Inhibitors to Dolutegravir: Post hoc Analysis of the 48-week Randomised Second-line Switch to Dolutegravir TrialLoice Achieng Ombajo, Jeremy Penner, Joseph Nkuranga, et al.
Epidemics|July 22, 2022
Infectious disease modelling for SARS-CoV-2 in Africa to guide policy: A systematic reviewTeresia Njoki Kimani, Mutono Nyamai, Lillian Owino, et al.
The Lancet. HIV|May 2, 2024
Two-drug regimens for the treatment of HIV in AfricaIvan Mambule, Claire Norcross, Loice Achieng Ombajo, et al.
The Lancet. Global Health|August 12, 2022
The COVID-19 pandemic and disruptions to essential health services in Kenya: a retrospective time-series analysisHelen Kiarie, Marleen Temmerman, Mutono Nyamai, et al.
Open Forum Infectious Diseases|November 24, 2025
First-Line Switch to B/F/TAF for Treatment of HIV in Older Adults ≥60 Years in Kenya (the B/F/TAF-Elderly Study)Loice Achieng Ombajo, Jeremy Penner, Joseph Nkuranga, et al.
IJID Regions|October 21, 2024
Investigation and successful control of a <i>Candida auris</i> outbreak at a tertiary health care facility in KenyaLoice Achieng Ombajo, Alice Kanyua, Rose Ngugi, et al.
BMJ Open|May 19, 2022
Epidemiological and clinical characteristics of patients hospitalised with COVID-19 in Kenya: a multicentre cohort studyLoice Achieng Ombajo, Nyamai Mutono, Paul Sudi, et al.
Pageof 2